Since emerging in prominence on the party scene in the 1980s, ecstasy has become a staple of festival and rave culture. But the drug also carries far more risks today than it did back then − and some ...
A panel of advisers to the U.S. health regulator on Tuesday voted against a therapy based on the party drug MDMA for patients with post-traumatic stress disorder, in a major setback to the nascent ...
"It may be that Ecstasy has detrimental long-term effects. We're advising caution before we go out and tell Ecstasy users that this is what will definitely happen to them." Ecstasy is known chemically ...
Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...
The Washington Post / The Washington Post via Getty Images In a matter of months, the Food and Drug Administration is expected to decide whether the drug commonly known as ecstasy can be used as a ...
This photo provided by the Center for Psychedelic Therapy Research shows a Yehuda Lab MDMA-assisted therapy treatment room at the James J. Peters Department of Veterans Affairs Medical Center in the ...
WASHINGTON — Medically retired with post-traumatic stress disorder, Jonathan Lubecky, a Marine Corps and Army veteran, said the anti-depressants and other prescribed medication that he took for his ...
A panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder. The meeting is the ...
"Yes, It's Trippy," from the visual journals of Cathy Malchiodi, PhD Source: ©2023 Cathy Malchiodi PhD, shared with permission. Self-experience is arguably at the center of all approaches to ...
MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...
Share on Pinterest A key FDA panel voted down approving MDMA-assisted therapy to treat PTSD. pixdeluxe/Getty Images An expert panel of the Food and Drug Administration reviewed two studies on ...
Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback